Biotech News

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology

Bruker (BRKR)BrukerCompany update

BRKR (BRKR) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is brkr.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

Bruker

Scientific Instrumentation Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales. Life-Science Research Its systems support molecular and cell biology, proteomics, multiomics, spatial and single-cell biology, structural biology and...

Recent company news

Stock data

Close
51.27 USD
Market cap
8.72B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States